Coloplast A/S (OTCMKTS:CLPBY) Upgraded at Sanford C. Bernstein

Sanford C. Bernstein upgraded shares of Coloplast A/S (OTCMKTS:CLPBY) to a hold rating in a report issued on Wednesday morning,Zacks.com reports.

Coloplast A/S Price Performance

OTCMKTS CLPBY opened at $8.45 on Wednesday. The company has a 50-day moving average price of $8.73 and a 200-day moving average price of $9.12. Coloplast A/S has a 52 week low of $8.34 and a 52 week high of $11.64. The company has a quick ratio of 1.00, a current ratio of 1.61 and a debt-to-equity ratio of 1.20. The firm has a market capitalization of $19.04 billion, a P/E ratio of 35.21, a PEG ratio of 0.84 and a beta of 0.26.

Coloplast A/S (OTCMKTS:CLPBY) last announced its earnings results on Tuesday, November 4th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.02). Coloplast A/S had a net margin of 13.01% and a return on equity of 24.99%. The business had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.10 billion. Equities research analysts anticipate that Coloplast A/S will post 0.31 earnings per share for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.